Well-established experimental data support the concept that defective IL-23/IL-17 axis activation contributes to the development of several autoimmune (e.g., IBD, RA, SS, MS) and inflammatory diseases, including endometriosis (294). This evidence concerns the gene IL37 and endometriosis.